Malta - English - Medicines Authority

piramal healthcare uk limited - sevoflurane 100 % (w/w) - inhalation vapour, liquid

Canada - English - Health Canada

baxter corporation - sevoflurane - liquid - 99.97% - sevoflurane 99.97% - inhalation anesthetics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - sevoflurane - inhalation vapour - 1ml/1ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

piramal pharma limited - sevoflurane - liquid for inhalation - 100%

United States - English - NLM (National Library of Medicine)

lannett company, inc. - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sevoflurane should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used. • known or suspected genetic susceptibility to malignant hyperthermia (see warnings- malignant hyperthermia, clinical pharmacology - pharmacogenomics). • known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

United States - English - NLM (National Library of Medicine)

shandong new time pharmaceutical co., ltd. - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sevoflurane should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used. • known or suspected genetic susceptibility to malignant hyperthermia (see warnings- malignant hyperthermia, clinical pharmacology - pharmacogenomics). • known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane, usp is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sevoflurane, usp should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane, usp should be used. • known or suspected genetic susceptibility to malignant hyperthermia. (see warnings - malignant hyperthermia, clinical pharmacology - pharmacogenomics ). • known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

United States - English - NLM (National Library of Medicine)

nextsource pharma - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sevoflurane should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used. - known or suspected genetic susceptibility to malignant hyperthermia (see warnings - malignant hyperthermia , clinical pharmacology - pharmacogenomics ). - known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

United States - English - NLM (National Library of Medicine)

aspen veterinary resources ltd - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane is indicated for induction and maintenance of general anesthesia in dogs. sevoflurane is contraindicated in dogs with a known sensitivity to sevoflurane or other halogenated agents.

Ireland - English - HPRA (Health Products Regulatory Authority)

piramal critical care limited - sevoflurane - inhalation vapour, liquid - 100 percent volume/volume - halogenated hydrocarbons; sevoflurane